Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics

Neogen (NEOG) reported $209.19 million in revenue for the quarter ended August 2025, representing a year-over-year decline of 3.6%. EPS of $0.04 for the same period compares to $0.07 a year ago.

The reported revenue represents a surprise of +2.96% over the Zacks Consensus Estimate of $203.18 million. With the consensus EPS estimate being $0.05, the EPS surprise was -20%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Neogen performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenues- Food Safety- Natural Toxins & Allergens: $19.96 million versus $18.68 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -2% change.
• Revenues- Food Safety- Bacterial & General Sanitation: $41.65 million compared to the $38.7 million average estimate based on two analysts. The reported number represents a change of +4.4% year over year.
• Revenues- Food Safety- Indicator Testing, Culture Media & Other: $79.09 million versus $76.43 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -3.2% change.
• Revenues- Animal Safety- Life Sciences: $1.86 million versus the two-analyst average estimate of $1.82 million. The reported number represents a year-over-year change of +7.3%.
• Revenues- Animal Safety- Animal Care & Other: $7.58 million versus $8.16 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +13.5% change.
• Revenues- Animal Safety: $57.14 million versus the two-analyst average estimate of $54.65 million. The reported number represents a year-over-year change of -0.8%.
• Revenues- Food Safety: $152.05 million versus $146.62 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -4.6% change.
• Revenues- Animal Safety- Genomics Services: $16.57 million versus the two-analyst average estimate of $4.42 million. The reported number represents a year-over-year change of +4.3%.
• Revenues- Food Safety- Genomics Services: $5.56 million compared to the $13.26 million average estimate based on two analysts. The reported number represents a change of -0.6% year over year.
• Revenues- Animal Safety- Veterinary Instruments & Disposables: $11.91 million compared to the $13.94 million average estimate based on two analysts. The reported number represents a change of -4.9% year over year.

View all Key Company Metrics for Neogen here>>>

Shares of Neogen have returned +4.1% over the past month versus the Zacks S&P 500 composite's +4% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

 
Neogen Corporation (NEOG): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research